About Xenter
Xenter is a private company based in Draper, Utah, incorporated in 2020 in Delaware. It has reported $23,531,012 raised in three offerings on Form D since January 2021.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Dec 23, 2022 | Jan 6, 2023 | $1,131,800of $40.0M target | 12 | $94,317 | Equity, Securities on exerciseRule 506(b) | Form D ↗ |
| Jun 30, 2021 | Jul 14, 2021amended Jan 6, 2023 | $19,595,500of $20.0M target | 79 | $248K | DebtRule 506(b) | Form D/A ↗1 earlier filing |
| Dec 31, 2020 | Jan 8, 2021 | $2,803,712of $12.0M target | 22 | $127K | EquityRule 506(b) | Form D ↗ |
| Total, three offerings | $23,531,012 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Xenter's Form D filed Jan 6, 2023.
JT
James Tobin
Director
Robert Langer
Director
Also a director at SunBird Bio and Syntis Bio and a co-founder & scientific advisor, director at SUTOL Bio.
EE
Elazer Edelman
Director
RL
Richard Linder
Executive officer and director
MS
Mark Stautberg
Director
EP
Eric Pearson
Exec. VP & General Counsel
RB
Robert Baxter
Executive officer and director
Earlier filings also listed David Sampson (executive officer, last listed Jan 2021).